a new ORAL med, Tecfidera (TEK-fi-de-rah, dimethyl fumarate), for treating multiple sclerosis

June 2013

You'll hear about a new ORAL med, Tecfidera (TEK-fi-de-rah, dimethyl fumarate), for treating multiple sclerosis.

Think of it as an alternative to Gilenya (fingolimod) to reduce the number of multiple sclerosis "flare-ups."

Both are oral capsules...and cost over $2000/month.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Pharmacy Technicians our top 5 tips that will help you prevent errors when you input Rxs
High-Alert Meds Medication errors continue to happen with insulin, opioid pain meds, chemotherapy, methotrexate, and other high-alert meds
Antihypertensives two new "ARB" blood pressure meds, Edarbi (eh-DAR-bee) and Edarbyclor (eh-DAR-bih-clor)
Insomnia whether zopiclone and other "non-benzo" insomnia meds are safer than benzodiazepines for elderly patients
Parkinson's Disease a new patch, Neupro (NU-pro, rotigotine), hit your pharmacy shelves
PPIs how to handle interactions with clopidogrel (Plavix, etc) and "PPI" stomach acid reducers (omeprazole, etc)
Antibiotics more focus on treating patients with Clostridium difficile (C. diff) diarrhea
Multiple Sclerosis a new ORAL med, Tecfidera (TEK-fi-de-rah, dimethyl fumarate), for treating multiple sclerosis
Supplements if enzyme supplements help gas and bloating
Smoking Cessation patients using OTC nicotine replacement therapy do NOT have to stop smoking first
Gastroenterology treating "gastroparesis" stomach problems, especially in patients with diabetes
Supplements the safety and benefits of L-carnitine
Diabetes One out of three Canadians will have prediabetes or diabetes by the year 2020